Senna-S

Manufacturer: Pharbest Pharmaceuticals, Inc.
Effective date: 2025-12-24
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: full-release
Hydrated at: 2026-06-01 01:28:18

Label at a glance#

ProductSenna-S

Active ingredientSENNOSIDES, DOCUSATE SODIUM

Label structure9 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces a bowel movement in 6-12 hours

Dosage and administration

take preferably at bedtime or as directed by a doctor age starting dosage maximum dosage Adults and children 12 years and over 2 tablets once a day 4 tablets twice a day Children 6 to under 12 years 1 tablet once a day 2 tablets twice a day Children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day Children under 2 years ask a doctor ask a doctor

Storage and handling

each tablet contains 10 mg of calcium, sodium 5 mg store at 25°(77°F); excursions permitted between 15 o -30 o C (59 o -86 o F) Tamper Evident: Do not use if safetyseal under cap is broken or missing

Contacts and useful links#

PhoneLabel contact(866) 562-2756

Label contents#

Full prescribing information#

Active Ingredients (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides from Senna Concentrate 8.6mg

Docusate Sodium 50mg

Purpose

OTC - PURPOSE SECTION

Laxative

Stool Softner

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)
generally produces a bowel movement in 6-12 hours

Warnings

WARNINGS SECTION

Do not use

laxative products for longer than 1 week unless directed by a doctor
if you are taking mineral oil, unless directed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

OTC - STOP USE SECTION

you have rectal bleeding or fail to have a bowel movement after the use of a laxative. These may indicate a serious condition.

If pregnant or breast feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a healthcare professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
Adults and children 12 years and over	2 tablets once a day	4 tablets twice a day
Children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
Children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
Children under 2 years	ask a doctor	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains 10 mg of calcium, sodium 5 mg
store at 25°(77°F); excursions permitted between 15^o-30^oC (59^o-86^oF)
Tamper Evident: Do not use if safetyseal under cap is broken or missing

Inactive ingredients

INACTIVE INGREDIENT SECTION

crosscarmellose Sodium, D&C Yellow# 10, dicalcium phosphate, FD&C Yellow #6, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, polyethylene glycol, sodium benzoate, talc, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

(866) 562-2756 Mon-Fri 8 AM to 4 PM EST

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PHARBEST

NDC 16103-378-08

Manufactured in the USA

^*Compare to the active ingredients in Senokot-S^®

SENNA-S

Sennosides 8.6mg &

Docusate Sodium 50mg

Natural Vegetable Laxative

Ingredient Plus Stool Softner

100 TABLETS

Senna 8.6 mg & Docusate Sodium 50 mg Orange tablet Product Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
998740	sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet	PSN	3
998740	docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SCD	3
998740	DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet	SY	3

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
16103-378-07	2024-12-31	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts
16103-378-08	2024-12-31	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts
16103-378-11	2024-12-31	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts
16103-378-07	2022-01-28	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts
16103-378-08	2022-01-28	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts
16103-378-11	2022-01-28	C162847	48780-1	d6a99b39-9e4f-a426-e053-dadaa90af4c2	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
16103-378-07	Senna-S	60 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	60	3
16103-378-08	Senna-S	100 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	100	3
16103-378-11	Senna-S	1000 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	1000	3

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
16103-378-11	EA - Each	16103-378	011d0b12-3043-4597-a0fa-fbe72c961b7d	1	2019-03-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

Senna-S
Sennosides 8.6mg and Docusate Sodium 50mg
SENNOSIDES
DOCUSATE SODIUM
DOCUSATE
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
FD&C YELLOW NO. 6
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
POLYVINYL ALCOHOL, UNSPECIFIED
POLYETHYLENE GLYCOL, UNSPECIFIED
SODIUM BENZOATE
TALC
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
16103-378	16103-378-07, 16103-378-11, 16103-378-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SENNOSIDES	3FYP5M0IJX	ACTIB
DOCUSATE SODIUM	F05Q2T2JA0	ACTIB
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
D&C YELLOW NO. 10	35SW5USQ3G	IACT
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE	O7TSZ97GEP	IACT
FD&C YELLOW NO. 6	H77VEI93A8	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
POLYVINYL ALCOHOL, UNSPECIFIED	532B59J990	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Senna-S	SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG	Pharbest Pharmaceuticals, Inc.	2b5152b2-d354-409f-a19f-b470f4181b3f	2025-12-24	Warnings	Exact identifier ndc (package): 16103-378-08 ndc (package): 16103-378-07 ndc (package): 16103-378-11 ndc (product): 16103-378 ndc11 (package): 16103037807 ndc11 (package): 16103037811 ndc11 (package): 16103037808 spl id: 0783ba51-f52a-4ac9-a5fe-ae0bfb6ef57c spl set id: 2b5152b2-d354-409f-a19f-b470f4181b3f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.